Since the first suspected case of coronavirus disease-2019 (COVID-19) on December 1st,
2019, in Wuhan, Hubei Province, China, a total of 40,235 confirmed cases and 909 deaths …

Background The emergence of the novel coronavirus in Wuhan, Hubei Province, China, in
December 2019 marked the synchronization of the world to a peculiar clock that is counting …

Background Data on the rate and severity of SARS-CoV-2 reinfections in real-world settings
are scarce and the effects of vaccine boosters on reinfection risk are unknown. Methods In a …

This study aimed to examine the associations with epidemiological, behavioral and clinical
parameters of IgG antibody responses against the spike protein of severe acute respiratory …

Introduction Italy became the second epicenter of the novel coronavirus disease 2019 (COVID-19)
pandemic after China, surpassing by far China’s death toll. The disease swept …

We retrieved data on 8940 anaphylaxis cases post-COVID-19 vaccination from the US
Vaccine Adverse Event Reporting System and the European EudraVigilance from week 52/2020 …

We are reviewing the current state of knowledge on the virological and immunological
correlates of long COVID, focusing on recent evidence for the possible association between the …

We developed an agent-based model to investigate the epidemic dynamics of Ebola virus
disease (EVD) in Liberia and Sierra Leone from May 27 to December 21, 2014. The dynamics …

We have investigated the mechanism of resistance of a HIV type 1 (HIV-1) R5 primary
isolate, D1/85.16, to the small molecule CCR5 inhibitor, vicriviroc (VVC). Unlike other viruses …

Acute myocarditis is the second most common inflammatory heart disease after pericarditis,
with an estimated annual incidence of 22 cases per 100,000 subjects [1]. The absence of …